Shares of Versigent (NYSE:VGNT – Get Free Report) have earned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $54.00.
VGNT has been the topic of several recent research reports. Wells Fargo & Company boosted their price target on shares of Versigent from $48.00 to $56.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. The Goldman Sachs Group cut their price objective on shares of Versigent from $59.00 to $58.00 and set a “buy” rating for the company in a research report on Tuesday, October 6th. Fox Advisors cut shares of Versigent from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, August 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $54.00 target price on shares of Versigent in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada raised their price target on shares of Versigent from $52.00 to $53.00 and gave the stock an “outperform” rating in a report on Monday.
Get Our Latest Analysis on Versigent
Versigent Trading Up 1.1%
NYSE VGNT traded up $0.46 on Friday, reaching $44.17. 794,704 shares of the company were exchanged, compared to its average volume of 772,663. The company has a debt-to-equity ratio of 7.29, a current ratio of 1.40 and a quick ratio of 1.09. The firm has a fifty day simple moving average of $46.33. The company has a market cap of $3.13 billion and a PE ratio of 23.01. Versigent has a fifty-two week low of $26.34 and a fifty-two week high of $50.88.
Versigent (NYSE:VGNT – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.34. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.29 billion. Equities research analysts forecast that Versigent will post 7.23 earnings per share for the current year.
Versigent Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Friday, September 4th were given a $0.13 dividend. This represents a $0.52 annualized dividend and a yield of 1.2%. The ex-dividend date was Friday, September 4th.
Insider Transactions at Versigent
In other news, Director Kevin Clark sold 47,761 shares of the company’s stock in a transaction on Thursday, October 8th. The stock was sold at an average price of $44.36, for a total value of $2,118,677.96. Following the transaction, the director owned 27,571 shares of the company’s stock, valued at $1,223,049.56. This represents a 63.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold a total of 220,000 shares of company stock worth $10,065,848 over the last ninety days.
Institutional Trading of Versigent
Hedge funds and other institutional investors have recently modified their holdings of the business. Fortitude Family Office LLC raised its holdings in Versigent by 497.1% in the 3rd quarter. Fortitude Family Office LLC now owns 621 shares of the company’s stock valued at $28,000 after buying an additional 517 shares during the period. Farther Finance Advisors LLC boosted its stake in Versigent by 53.1% during the third quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock worth $47,000 after buying an additional 365 shares during the period. Integrated Wealth Concepts LLC purchased a new position in Versigent during the second quarter worth about $57,000. GAMMA Investing LLC boosted its stake in Versigent by 54.8% during the third quarter. GAMMA Investing LLC now owns 2,249 shares of the company’s stock worth $101,000 after buying an additional 796 shares during the period. Finally, Sequoia Financial Advisors LLC acquired a new stake in shares of Versigent during the second quarter valued at about $220,000.
Versigent Company Profile
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
See Also
- Five stocks we like better than Versigent
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
